Ionis Pharmaceuticals

Member

Ionis Pharmaceuticals is exploiting its expertise in RNA to discover and develop novel human therapeutic drugs for patients. The company is also developing a biosensor to identify infectious organisms.

Ionis Pharmaceuticals's Articles

Ionis Pharmaceuticals's articles RSS

Page 2 of 2

Serine / threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling

Authors: David A Dean, Gudrun Urban, Ileana V Aragon, Mark Swingle, Beth Miller, Sandro Rusconi, Manuel Bueno, Nicholas M Dean and Richard E Honkanen

Citation: BMC Cell Biology 2001 2:6

Content type: Research article Published on: 17 May 2001

Previous page
1
2
Next page